{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:50:55Z","timestamp":1773294655007,"version":"3.50.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNPPY"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1093\/ijnp\/pyv111","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T01:34:55Z","timestamp":1443749695000},"page":"pyv111","source":"Crossref","is-referenced-by-count":13,"title":["Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study"],"prefix":"10.1093","volume":"19","author":[{"given":"Chris A.","family":"Oosterhof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa El","family":"Mansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer","family":"Bundgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"2016031417584958000_19.3.pyv111.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00069-9"},{"key":"2016031417584958000_19.3.pyv111.2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2012.0536"},{"key":"2016031417584958000_19.3.pyv111.3","doi-asserted-by":"publisher","DOI":"10.1007\/BF00165127"},{"key":"2016031417584958000_19.3.pyv111.4","first-page":"30","article-title":"Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety","volume":"66","author":"Blier","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"2016031417584958000_19.3.pyv111.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01643-8"},{"key":"2016031417584958000_19.3.pyv111.6","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1523\/JNEUROSCI.06-10-02796.1986","article-title":"In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals","volume":"6","author":"Chaput","year":"1986","journal-title":"J Neurosci"},{"key":"2016031417584958000_19.3.pyv111.7","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.140"},{"key":"2016031417584958000_19.3.pyv111.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1611-7"},{"key":"2016031417584958000_19.3.pyv111.9","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.18"},{"key":"2016031417584958000_19.3.pyv111.10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1523\/JNEUROSCI.03-08-01607.1983","article-title":"Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons","volume":"3","author":"Chiodo","year":"1983","journal-title":"J Neurosci"},{"key":"2016031417584958000_19.3.pyv111.11","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90196-5"},{"key":"2016031417584958000_19.3.pyv111.12","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108089586"},{"key":"2016031417584958000_19.3.pyv111.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.725608"},{"key":"2016031417584958000_19.3.pyv111.14","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)90927-0"},{"key":"2016031417584958000_19.3.pyv111.15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-3565(24)37717-1","article-title":"Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe","volume":"286","author":"Dong","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"2016031417584958000_19.3.pyv111.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.05.015"},{"key":"2016031417584958000_19.3.pyv111.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0818-8"},{"key":"2016031417584958000_19.3.pyv111.18","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.169417"},{"key":"2016031417584958000_19.3.pyv111.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2260-1"},{"key":"2016031417584958000_19.3.pyv111.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.11.001"},{"key":"2016031417584958000_19.3.pyv111.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.11.005"},{"key":"2016031417584958000_19.3.pyv111.22","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1523\/JNEUROSCI.04-11-02877.1984","article-title":"The control of firing pattern in nigral dopamine neurons: burst firing","volume":"4","author":"Grace","year":"1984","journal-title":"J Neurosci"},{"key":"2016031417584958000_19.3.pyv111.23","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1523\/JNEUROSCI.18-23-10150.1998","article-title":"Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors","volume":"18","author":"Haddjeri","year":"1998","journal-title":"J Neurosci"},{"key":"2016031417584958000_19.3.pyv111.24","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01616.x"},{"key":"2016031417584958000_19.3.pyv111.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05276.x"},{"key":"2016031417584958000_19.3.pyv111.26","doi-asserted-by":"publisher","DOI":"10.1177\/026988110401800308"},{"key":"2016031417584958000_19.3.pyv111.27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301646"},{"key":"2016031417584958000_19.3.pyv111.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.01.038"},{"key":"2016031417584958000_19.3.pyv111.29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300027"},{"key":"2016031417584958000_19.3.pyv111.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)00910-2"},{"key":"2016031417584958000_19.3.pyv111.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.17.9235"},{"key":"2016031417584958000_19.3.pyv111.32","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.213819"},{"key":"2016031417584958000_19.3.pyv111.33","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.213793"},{"key":"2016031417584958000_19.3.pyv111.34","doi-asserted-by":"publisher","DOI":"10.1007\/BF00167444"},{"key":"2016031417584958000_19.3.pyv111.35","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.218578"},{"key":"2016031417584958000_19.3.pyv111.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.01.006"},{"key":"2016031417584958000_19.3.pyv111.37","unstructured":"Oosterhof NN Oosterhof CA (2013) BurstiDAtor: a lightweight discharge analysis program for neural extracellular single unit recordings. https:\/\/github.com\/nno\/burstiDAtor. Retrieved 21 Oct 2014."},{"key":"2016031417584958000_19.3.pyv111.38","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1523\/JNEUROSCI.14-05-03036.1994","article-title":"Desensitization of the neuronal 5-HT carrier following its long-term blockade","volume":"14","author":"Pi\u00f1eyro","year":"1994","journal-title":"J Neurosci"},{"key":"2016031417584958000_19.3.pyv111.39","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)91411-3"},{"key":"2016031417584958000_19.3.pyv111.40","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(73)90030-7"},{"key":"2016031417584958000_19.3.pyv111.41","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.795945"},{"key":"2016031417584958000_19.3.pyv111.42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3565(24)37461-0","article-title":"Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems","volume":"285","author":"Rueter","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"2016031417584958000_19.3.pyv111.43","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2198-2"},{"key":"2016031417584958000_19.3.pyv111.44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1145194"},{"key":"2016031417584958000_19.3.pyv111.45","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107082944"},{"key":"2016031417584958000_19.3.pyv111.46","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00260-R"},{"key":"2016031417584958000_19.3.pyv111.47","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.2414"},{"key":"2016031417584958000_19.3.pyv111.48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S1092852900016382","article-title":"Do dopamine partial agonists have partial efficacy as antipsychotics?","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr"},{"key":"2016031417584958000_19.3.pyv111.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0621-y"},{"key":"2016031417584958000_19.3.pyv111.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.01.021"},{"key":"2016031417584958000_19.3.pyv111.51","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(75)90276-0"},{"key":"2016031417584958000_19.3.pyv111.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)03121-3"},{"key":"2016031417584958000_19.3.pyv111.53","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.712114"},{"issue":"9","key":"2016031417584958000_19.3.pyv111.54","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4088\/JCP.14m09688","article-title":"Efficacy and safety of adjunctive brexpiprazole 2mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants","volume":"76","author":"Thase","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"2016031417584958000_19.3.pyv111.55","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4088\/JCP.14m09689","article-title":"Adjunctive brexpiprazole 1 and 3mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study","volume":"76","author":"Thase","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"2016031417584958000_19.3.pyv111.56","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(83)90011-2"},{"key":"2016031417584958000_19.3.pyv111.57","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90222-5"},{"key":"2016031417584958000_19.3.pyv111.58","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00711-0"},{"key":"2016031417584958000_19.3.pyv111.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.06.008"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:04:45Z","timestamp":1748642685000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1093\/ijnp\/pyv111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,14]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1093\/ijnp\/pyv111"],"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyv111","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}